The Leadership Team at PhaseBio is responsible for setting the strategic direction and overseeing the overall operations of the company. Comprising key executives, including the Chief Medical Officer and SVPs of various functions, the team collaborates to drive the development and commercialization of innovative therapies for cardiovascular and cardiopulmonary diseases, ensuring alignment with regulatory requirements and scientific advancements. Their collective expertise guides critical decision-making and fosters a culture of excellence within the organization.
View all